{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:20:21Z","timestamp":1793388021529,"version":"4.5.0"},"reference-count":59,"publisher":"MDPI AG","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Training Plan for Thousands of Young and Middle-aged Key Teachers in Colleges and Universities of Guangxi (The third batch)","award":["2020GXNSFAA259020"],"award-info":[{"award-number":["2020GXNSFAA259020"]}]},{"name":"Guangxi Traditional Chinese Medicine Excellent Talent Training Program","award":["2020GXNSFAA259020"],"award-info":[{"award-number":["2020GXNSFAA259020"]}]},{"name":"Guangxi Natural Science Foundation","award":["2020GXNSFAA259020"],"award-info":[{"award-number":["2020GXNSFAA259020"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CIMB"],"abstract":"<jats:p>The objective of this study is to investigate the effects of kynurenine-3-monooxygenase (KMO) inhibition on seizures, depressive-like behaviors, and cognitive functions in epileptic mice, and to elucidate its impact on the kynurenine metabolic pathway. Male Kunming (KM) mice were randomized into four groups: the epileptic model (EM), epileptic model treated with Ro 61-8048 (RM), healthy control (HC), and healthy control treated with Ro 61-8048 (RC). Chronic epilepsy was induced in the EM and RM groups via an intraperitoneal pilocarpine injection (225 mg\/kg). The RM and RC groups received Ro 61-8048 (42 mg\/kg). The seizure frequency was monitored continuously using a 24 h video recording. Depressive-like behaviors were assessed with the sucrose preference test (SPT) and forced swim test (FST); cognitive function was evaluated with the Y-maze test and open field test (OFT). The concentrations of kynurenine (KYN), kynurenic acid (KYNA), 3-hydroxykynurenine (3-HK), and 3-hydroxyanthranilic acid (3-HANA) were determined by liquid chromatography\u2013tandem mass spectrometry (LC\u2013MS\/MS). Compared to the EM group, the RM group exhibited a reduced seizure frequency and severity (p &lt; 0.05), ameliorated depressive-like behaviors (increased sucrose preference in SPT, and decreased immobility time in FST, p &lt; 0.05), and enhanced cognitive performance (elevated spontaneous alternation and reduced non-sequential alternation in a Y-maze, and increased time and distance in a central open field area, p &lt; 0.05). Mechanistically, compared to the RC group, the RM group showed an increased KYNA\/KYN ratio, and a decreased 3-HK\/KYN ratio (p &lt; 0.05) KMO inhibition rectifies the neurotoxic\u2013neuroprotective imbalance in the kynurenine pathway (downregulating the 3-HK\/3-HANA ratio and upregulating the KYNA\/KYN ratio), thereby decreasing seizures, depressive-like behaviors, and cognitive deficits. These findings suggest KMO inhibition is a potential therapeutic strategy for epilepsy-associated depression. A further investigation of its mechanisms and clinical applicability is warranted.<\/jats:p>","DOI":"10.3390\/cimb47090705","type":"journal-article","created":{"date-parts":[[2025,9,2]],"date-time":"2025-09-02T13:01:13Z","timestamp":1756818073000},"page":"705","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["KMO Inhibition Improves Seizures and Depressive-like Behaviors Without Aggravating Cognitive Impairment in Epileptic Mice"],"prefix":"10.3390","volume":"47","author":[{"given":"Jingwen","family":"Xu","sequence":"first","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi University of Chinese Medicine, No. 89-9 Dongge Road, Nanning 530023, China"},{"name":"Guangxi Key Laboratory of Molecular Biology of Traditional Chinese Medicine and Preventive Medicine, Nanning 530023, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifen","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi University of Chinese Medicine, No. 89-9 Dongge Road, Nanning 530023, China"},{"name":"Guangxi Key Laboratory of Molecular Biology of Traditional Chinese Medicine and Preventive Medicine, Nanning 530023, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Wei","sequence":"additional","affiliation":[{"name":"Department of Rehabilitation, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi University of Chinese Medicine, Nanning 530023, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziting","family":"Kong","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi University of Chinese Medicine, No. 89-9 Dongge Road, Nanning 530023, China"},{"name":"Guangxi Key Laboratory of Molecular Biology of Traditional Chinese Medicine and Preventive Medicine, Nanning 530023, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junling","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi University of Chinese Medicine, No. 89-9 Dongge Road, Nanning 530023, China"},{"name":"Guangxi Key Laboratory of Molecular Biology of Traditional Chinese Medicine and Preventive Medicine, Nanning 530023, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lun","family":"Cai","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Affiliated Hospital of Guangxi University of Chinese Medicine, Guangxi University of Chinese Medicine, No. 89-9 Dongge Road, Nanning 530023, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,9,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1097\/MOP.0000000000000825","article-title":"Long-term outcomes after childhood convulsive status epilepticus","volume":"31","author":"Pujar","year":"2019","journal-title":"Curr. Opin. Pediatr."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1212\/cont.0000000000001529","article-title":"Epilepsy Comorbidities","volume":"31","author":"Keezer","year":"2025","journal-title":"Continuum"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00228-023-03597-y","article-title":"Antidepressant use and the risk of seizure: A meta-analysis of observational studies","volume":"80","author":"Yang","year":"2024","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.2174\/1570159X20666220524121645","article-title":"Pharmacokinetic Interactions Between Antiseizure and Psychiatric Medications","volume":"21","author":"Zaccara","year":"2023","journal-title":"Curr. Neuropharmacol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1111\/epi.17140","article-title":"ILAE clinical practice recommendations for the medical treatment of depression in adults with epilepsy","volume":"63","author":"Mula","year":"2022","journal-title":"Epilepsia"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.seizure.2021.04.021","article-title":"Effects of perceived stigma, unemployment and depression on suicidal risk in people with epilepsy","volume":"91","author":"Zhao","year":"2021","journal-title":"Seizure"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.seizure.2024.06.016","article-title":"Risk factors of suicide-related events in patients with epilepsy: A systematic review and meta-analysis","volume":"120","author":"Zhang","year":"2024","journal-title":"Seizure"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/npp.2011.277","article-title":"Interleukin-1\u03b2: A new regulator of the kynurenine pathway affecting human hippocampal neurogenesis","volume":"37","author":"Zunszain","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Deng, N., Hu, J., Hong, Y., Ding, Y., Xiong, Y., Wu, Z., and Xie, W. (2021). Indoleamine-2,3-Dioxygenase 1 Deficiency Suppresses Seizures in Epilepsy. Front. Cell. Neurosci., 15.","DOI":"10.3389\/fncel.2021.638854"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1002\/fsn3.1418","article-title":"Kynurenine-3-monooxygenase: A new direction for the treatment in different diseases","volume":"8","author":"Lu","year":"2020","journal-title":"Food Sci. Nutr."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s11055-008-0017-z","article-title":"Dopamine-dependent nature of depression-like behavior in WAG\/Rij rats with genetic absence epilepsy","volume":"38","author":"Sarkisova","year":"2008","journal-title":"Neurosci. Behav. Physiol."},{"key":"ref_12","first-page":"668","article-title":"Age-related changes in behavior, in monoamines and their metabolites content, and in density of D1 and D2 dopamine receptors in the brain structures of WAG\/Rij rats with depression-like pathology","volume":"64","author":"Sarkisova","year":"2014","journal-title":"Zhurnal Vyss. Nervn. Deiatelnosti Im. I P Pavlov."},{"key":"ref_13","first-page":"771","article-title":"The Effect of Chaihu Shugan Decoction on HPA Axis and Raphe-Hippocampus Serotoninergic Transmission in Epileptic Rats with Depressive-like Behavior Resistant to Fluoxetine","volume":"30","author":"Wei","year":"2019","journal-title":"Tradit. Chin. Drug Res. Clin. Pharmacol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/sj.mp.4001093","article-title":"NMDA receptor antagonists ketamine and PCP have direct effects on the dopamine D2 and serotonin 5-HT2 receptors-implications for models of schizophrenia","volume":"7","author":"Kapur","year":"2002","journal-title":"Mol. Psychiatry"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pnpbp.2013.04.009","article-title":"Monoamine neurocircuitry in depression and strategies for new treatments","volume":"45","author":"Hamon","year":"2013","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1528-1167.2008.01489.x","article-title":"Glial activation precedes seizures and hippocampal neurodegeneration in measles virus-infected mice","volume":"49","author":"Lehrmann","year":"2008","journal-title":"Epilepsia"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e918","DOI":"10.1038\/tp.2016.200","article-title":"Neurotoxic kynurenine metabolism is increased in the dorsal hippocampus and drives distinct depressive behaviors during inflammation","volume":"6","author":"Parrott","year":"2016","journal-title":"Transl. Psychiatry"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrd.2017.16","article-title":"Targeting glutamate signalling in depression: Progress and prospects","volume":"16","author":"Murrough","year":"2017","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1111\/j.1471-4159.1989.tb01881.x","article-title":"A glycine site associated with N-methyl-D-aspartic acid receptors: Characterization and identification of a new class of antagonists","volume":"52","author":"Kessler","year":"1989","journal-title":"J. Neurochem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/schbul\/sbq002","article-title":"Cortical kynurenine pathway metabolism: A novel target for cognitive enhancement in Schizophrenia","volume":"36","author":"Wonodi","year":"2010","journal-title":"Schizophr. Bull."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"S152","DOI":"10.1093\/schbul\/sbt157","article-title":"Targeting kynurenine aminotransferase II in psychiatric diseases: Promising effects of an orally active enzyme inhibitor","volume":"40","author":"Wu","year":"2014","journal-title":"Schizophr. Bull."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Sathyasaikumar, K.V., Notarangelo, F.M., Kelly, D.L., Rowland, L.M., Hare, S.M., Chen, S., Mo, C., Buchanan, R.W., and Schwarcz, R. (2022). Tryptophan Challenge in Healthy Controls and People with Schizophrenia: Acute Effects on Plasma Levels of Kynurenine, Kynurenic Acid and 5-Hydroxyindoleacetic Acid. Pharmaceuticals, 15.","DOI":"10.3390\/ph15081003"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Sapienza, J., Agostoni, G., Repaci, F., Spangaro, M., Comai, S., and Bosia, M. (2025). Metabolic Syndrome and Schizophrenia: Adding a Piece to the Interplay Between the Kynurenine Pathway and Inflammation. Metabolites, 15.","DOI":"10.3390\/metabo15030176"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Cho, C.H. (2013). New mechanism for glutamate hypothesis in epilepsy. Front. Cell. Neurosci., 7.","DOI":"10.3389\/fncel.2013.00127"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.neuint.2016.09.012","article-title":"Kynurenine pathway metabolism following prenatal KMO inhibition and in Mecp2+\/\u2212 mice, using liquid chromatography-tandem mass spectrometry","volume":"100","author":"Forrest","year":"2016","journal-title":"Neurochem. Int."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainres.2014.06.016","article-title":"Modified neocortical and cerebellar protein expression and morphology in adult rats following prenatal inhibition of the kynurenine pathway","volume":"1576","author":"Pisar","year":"2014","journal-title":"Brain Res."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.1021\/jm970467t","article-title":"Synthesis and biochemical evaluation of N-(4-phenylthiazol-2-yl) benzenesulfonamides as high-affinity inhibitors of kynurenine 3-hydroxylase","volume":"40","author":"Cesura","year":"1997","journal-title":"J. Med. Chem."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0013-4694(72)90177-0","article-title":"Modification of seizure activity by electrical stimulation. II. Motor seizure","volume":"32","author":"Racine","year":"1972","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.neuropharm.2018.04.016","article-title":"Increasing kynurenine brain levels reduces ethanol consumption in mice by inhibiting dopamine release in nucleus accumbens","volume":"135","author":"Vidal","year":"2018","journal-title":"Neuropharmacology"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1128\/IAI.73.8.5249-5251.2005","article-title":"Prolonged survival of a murine model of cerebral malaria by kynurenine pathway inhibition","volume":"73","author":"Clark","year":"2005","journal-title":"Infect. Immun."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1007\/s00213-016-4384-9","article-title":"Metabolic shift of the kynurenine pathway impairs alcohol and cocaine seeking and relapse","volume":"233","author":"Vengeliene","year":"2016","journal-title":"Psychopharmacology"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Zhao, Y.T., Yin, H., Hu, C., Zeng, J., Zhang, S., Chen, S., Zheng, W., Li, M., Jin, L., and Liu, Y. (2022). Tilapia Skin Peptides Ameliorate Cyclophosphamide-Induced Anxiety- and Depression-Like Behavior via Improving Oxidative Stress, Neuroinflammation, Neuron Apoptosis, and Neurogenesis in Mice. Front. Nutr., 9.","DOI":"10.3389\/fnut.2022.882175"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.euroneuro.2023.08.496","article-title":"Sucrose preference test: A systematic review of protocols for the assessment of anhedonia in rodents","volume":"77","author":"Primo","year":"2023","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.bbrc.2019.08.061","article-title":"Trans-cinnamaldehyde shows anti-depression effect in the forced swimming test and possible involvement of the endocannabinoid system","volume":"518","author":"Lin","year":"2019","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/0278-5846(90)90073-P","article-title":"Neurobehavioral studies of forced swimming: The role of learning and memory in the forced swim test","volume":"14","author":"West","year":"1990","journal-title":"Prog. Neuro Psychopharmacol. Biol. Psychiatry"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"110583","DOI":"10.1016\/j.yebeh.2025.110583","article-title":"Acute dose-related effect of antiseizure medications on open field exploration of male rats with established epilepsy","volume":"171","author":"Wu","year":"2025","journal-title":"Epilepsy Behav."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"119700","DOI":"10.1016\/j.jep.2025.119700","article-title":"Chaihu-Shugan-San alleviates post-stroke depression in mice: Mechanistic insights into exosome-mediated neuroprotection","volume":"347","author":"Wu","year":"2025","journal-title":"J. Ethnopharmacol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"11786469211041368","DOI":"10.1177\/11786469211041368","article-title":"Blockade of KAT II Facilitates LTP in Kynurenine 3-Monooxygenase Depleted Mice","volume":"14","author":"Imbeault","year":"2021","journal-title":"Int. J. Tryptophan Res."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Milosavljevic, S., Piroli, M.V., Sandago, E.J., Piroli, G.G., Smith, H.H., Beggiato, S., Frizzell, N., and Pocivavsek, A. (2025). Parental kynurenine 3-monooxygenase genotype in mice directs sex-specific behavioral outcomes in offspring. Biol. Sex Differ., 16.","DOI":"10.1186\/s13293-025-00703-w"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"E274","DOI":"10.1152\/ajpendo.00386.2024","article-title":"Constitutive loss of kynurenine-3-monooxygenase changes circulating kynurenine metabolites without affecting systemic energy metabolism","volume":"328","author":"Dumont","year":"2025","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.jphs.2024.12.003","article-title":"Thrombin-induced kynurenine 3-monooxygenase causes variations in the kynurenine pathway, leading to neurological deficits in a murine intracerebral hemorrhage model","volume":"157","author":"Ohnishi","year":"2025","journal-title":"J. Pharmacol. Sci."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejphar.2003.08.038","article-title":"The kynurenine 3-hydroxylase inhibitor Ro 61-8048 improves dystonia in a genetic model of paroxysmal dyskinesia","volume":"478","author":"Richter","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"ref_43","doi-asserted-by":"crossref","unstructured":"Parrott, J.M., and O\u2019Connor, J.C. (2015). Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology. Front. Psychiatry, 6.","DOI":"10.3389\/fpsyt.2015.00116"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1586\/14737175.2015.1049999","article-title":"What is the tryptophan kynurenine pathway and why is it important to neurotherapeutics?","volume":"15","author":"Davis","year":"2015","journal-title":"Expert. Rev. Neurother."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/jnr.24489","article-title":"Modification of kynurenine pathway via inhibition of kynurenine hydroxylase attenuates surgical brain injury complications in a male rat model","volume":"98","author":"Zakhary","year":"2020","journal-title":"J Neurosci Res"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.pharep.2013.11.007","article-title":"Modulation by kynurenine of extracellular kynurenate and glutamate in cerebral cortex of rats with acute liver failure","volume":"66","author":"Hilgier","year":"2014","journal-title":"Pharmacol. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1007\/s11064-016-2105-8","article-title":"Mechanisms of Excessive Extracellular Glutamate Accumulation in Temporal Lobe Epilepsy","volume":"42","author":"Albrecht","year":"2017","journal-title":"Neurochem. Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2147\/NDT.S239763","article-title":"Increased Plasma Kynurenic Acid Levels are Associated with Impaired Attention\/Vigilance and Social Cognition in Patients with Schizophrenia","volume":"16","author":"Huang","year":"2020","journal-title":"Neuropsychiatr Dis Treat"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Hasegawa, M., Niijima, M., Kunisawa, K., Teshigawara, T., Kubota, H., Fujigaki, S., Fujigaki, H., Yamamoto, Y., Kim, H.C., and Saito, K. (2024). Maternal immune activation induces neurodevelopmental impairments of adult offspring through alterations in tryptophane-kynurenine pathway in the placenta. Biochem. Biophys. Res. Commun., 737.","DOI":"10.1016\/j.bbrc.2024.150922"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"6839","DOI":"10.1038\/s41467-023-42295-2","article-title":"Multivalent Tau\/PSD-95 interactions arrest in vitro condensates and clusters mimicking the postsynaptic density","volume":"14","author":"Shen","year":"2023","journal-title":"Nat. Commun."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"123","DOI":"10.11604\/pamj.2016.24.123.8409","article-title":"Reduced plasma concentrations of vitamin B6 and increased plasma concentrations of the neurotoxin 3-hydroxykynurenine are associated with nodding syndrome: A case control study in Gulu and Amuru districts, Northern Uganda","volume":"24","author":"Obol","year":"2016","journal-title":"Pan Afr. Med. J."},{"key":"ref_52","first-page":"e21527","article-title":"Comorbidity of Epilepsy and Depression: Associated Pathophysiology and Management","volume":"14","author":"Alhashimi","year":"2022","journal-title":"Cureus"},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11481-024-10101-5","article-title":"New Insights on NLRP3 Inflammasome: Mechanisms of Activation, Inhibition, and Epigenetic Regulation","volume":"19","author":"Kodi","year":"2024","journal-title":"J. Neuroimmune Pharmacol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1016\/j.bbamcr.2016.09.014","article-title":"Quinolinic acid neurotoxicity: Differential roles of astrocytes and microglia via FGF-2-mediated signaling in redox-linked cytoskeletal changes","volume":"1863","author":"Pierozan","year":"2016","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_55","first-page":"68","article-title":"NF-\u03baB signaling pathway and inflammatory response","volume":"45","author":"Wang","year":"2014","journal-title":"Prog. Physiol. Sci."},{"key":"ref_56","first-page":"485","article-title":"Hippocampal kynurenines as etiological factors in seizure disorders","volume":"39","author":"Schwarcz","year":"1987","journal-title":"Pol. J. Pharmacol. Pharm."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1111\/j.1528-1167.2005.67404.x","article-title":"Kynurenate and 7-chlorokynurenate formation in chronically epileptic rats","volume":"46","author":"Wu","year":"2005","journal-title":"Epilepsia"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/mds.28202","article-title":"Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson\u2019s Disease","volume":"35","author":"Heilman","year":"2020","journal-title":"Mov. Disord."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s43440-020-00067-5","article-title":"Antidepressant-like effects of kynurenic acid in a modified forced swim test","volume":"72","author":"Tanaka","year":"2020","journal-title":"Pharmacol. Rep."}],"container-title":["Current Issues in Molecular Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1467-3045\/47\/9\/705\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:37:01Z","timestamp":1760035021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1467-3045\/47\/9\/705"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,1]]},"references-count":59,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2025,9]]}},"alternative-id":["cimb47090705"],"URL":"https:\/\/doi.org\/10.3390\/cimb47090705","relation":{},"ISSN":["1467-3045"],"issn-type":[{"value":"1467-3045","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,1]]}}}